Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study

被引：0
作者：
Einav Ratzon
Yousef Najajreh
Rami Salem
Hazem Khamaisie
Martin Ruthardt
Jamal Mahajna
机构：
[1] Cancer Drug Discovery Program,Anticancer Drugs Research Lab, Faculty of Pharmacy
[2] Migal,The Department of Nutritional Sciences
[3] Galilee Research Institute,undefined
[4] Al-Quds University,undefined
[5] Medizinische Klinik II/Abtl. Hämatologie,undefined
[6] Klinikum der Johann Wolfgang Goethe Universität,undefined
[7] Tel Hai College,undefined
来源：
BMC Cancer | / 16卷
关键词：
Platinum (IV); Cisplatin; Ovarian cancer; Resistance; Copper transporter (Ctr1);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 95 条
  • [1] Rosenberg B(1965)Inhibition of cell division in escherichia coli by electrolysis products from a platinum electrode Nature 205 698-9
  • [2] Vancamp L(2001)Cisplatin: from DNA damage to cancer chemotherapy Prog Nucleic Acid Res Mol Biol 67 93-130
  • [3] Krigas T(1990)Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance Cancer Cells 2 35-43
  • [4] Cohen SM(1999)Mechanisms of apoptosis avoidance in cancer Curr Opin Oncol 11 68-75
  • [5] Lippard SJ(1988)Overexpression of metallothionein confers resistance to anticancer drugs Science 241 1813-5
  • [6] Andrews PA(2010)Role of the Akt/mTOR survival pathway in cisplatin resistance in ovarian cancer cells Biochem Biophys Res Commun 394 600-5
  • [7] Howell SB(1993)New platinum antitumor complexes Crit Rev Oncol Hematol 15 191-219
  • [8] Reed JC(1998)Oxaliplatin: mechanism of action and antineoplastic activity Semin Oncol 25 4-12
  • [9] Kelley SL(2007)Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review Cancer Treat Rev 33 347-57
  • [10] Basu A(2007)Understanding cisplatin resistance using cellular models IUBMB Life 59 696-9
12345678910